Use of preclinical dog studies and absorption modeling to facilitate late stage formulation bridging for a BCS II drug candidate.
about
Use of preclinical dog studies and absorption modeling to facilitate late stage formulation bridging for a BCS II drug candidate.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Use of preclinical dog studies ...... g for a BCS II drug candidate.
@en
type
label
Use of preclinical dog studies ...... g for a BCS II drug candidate.
@en
prefLabel
Use of preclinical dog studies ...... g for a BCS II drug candidate.
@en
P2860
P1433
P1476
Use of preclinical dog studies ...... g for a BCS II drug candidate.
@en
P2093
Filippos Kesisoglou
P2860
P2888
P356
10.1208/S12249-013-0030-6
P407
P577
2014-02-01T00:00:00Z
P6179
1002343382